HemaSphere (Jun 2022)

S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA)

  • M. S. Infante,
  • J. Salmanton-García,
  • A. Fernandez-Cruz,
  • F. Marchesi,
  • Z. RÁČIL,
  • M. Hanakova,
  • O. Jaksic,
  • B. Weinbergerova,
  • C. Besson,
  • R. Duarte,
  • F. Itri,
  • T. VALKOVIĆ,
  • A. Busca,
  • A. Guidetti,
  • A. GLENTHØJ,
  • G. Collins,
  • V. Bonuomo,
  • U. Sili,
  • G. Seval,
  • M. Machado,
  • A. Lopez-Garcia,
  • R. Cordoba,
  • O. Blennow,
  • G. Abu-zeinah,
  • S. Lemure,
  • A. Kulasekararaj,
  • I. Falces-Romero,
  • C. Cattaneo,
  • O. A. Cornely,
  • J.-A. Hernandez-Rivas,
  • L. Pagano

DOI
https://doi.org/10.1097/01.HS9.0000844012.13018.0a
Journal volume & issue
Vol. 6
pp. 181 – 182

Abstract

Read online

No abstracts available.